US Patent Issued to INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, SEOUL NATIONAL UNIVERSITY HOSPITAL on May 6 for "Circulating tumor cell based biomarker composition for diagnosis and prognosis of metastatic prostate cancer" (South Korean Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,292,443, issued on May 6, was assigned to INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Gimhae-si, South Korea) and SEOUL NATIONAL UNIVERSITY HOSPITAL (Seoul, South Korea).

"Circulating tumor cell based biomarker composition for diagnosis and prognosis of metastatic prostate cancer" was invented by Jae Seung Chung (Busan, South Korea), Ki-Ho Han (Busan, South Korea), Hyung Seok Cho (Busan, South Korea), Jae Il Chung (Busan, South Korea) and Seok-Soo Byun (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a biomarker composition for diagnosing and predicting prognosis of prostate cancer, ...